SEARCH

SEARCH BY CITATION

References

  • Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K. P., Hamon M. and Adrien J. (2006) Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 26, 55545564.
  • Andrieux A., Salin P. A., Vernet M. et al. (2002) The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 16, 23502364.
  • Andrieux A., Salin P., Schweitzer A. et al. (2006) Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol. Psychiatry 60, 12241230.
  • Ansorge M. S., Morelli E. and Gingrich J. A. (2008) Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J. Neurosci. 28, 199207.
  • Ase A. R., Reader T. A., Hen R., Riad M. and Descarries L. (2001) Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 78, 619630.
  • Ayhan Y., Abazyan B. and Nomura J. et al. (2010) Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry. 16, 293306.
  • Beaulieu J. M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R. and Caron M. G. (2008) Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. USA 105, 13331338.
  • Begou M., Brun P., Bertrand J. B., Job D., Schweitzer A., D’Amato T., Saoud M., Andrieux A. and Suaud-Chagny M. F. (2007) Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse 61, 689697.
  • Begou M., Volle J., Bertrand J. B. et al. (2008) The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Neuroscience 157, 2939.
  • Belzung C. (2001) The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav. Pharmacol. 12, 451460.
  • Bevins R. A. and Besheer J. (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat. Protoc. 1, 13061311.
  • Blackwood D., Pickard B., Thomson P., Evans K., Porteous D. and Muir W. (2007) Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res. 11, 7383.
  • Bouvrais-Veret C., Weiss S., Andrieux A., Schweitzer A., McIntosh J. M., Job D., Giros B. and Martres M. P. (2007) Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology 52, 16911700.
  • Bouvrais-Veret C., Weiss S., Hanoun N., Andrieux A., Schweitzer A., Job D., Hamon M., Giros B. and Martres M. P. (2008) Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J. Neurochem. 104, 745756.
  • Brenner E., Sonnewald U., Schweitzer A., Andrieux A. and Nehlig A. (2007) Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J. Neurosci. Res. 85, 34873493.
  • Brown R. and Silva A. J. (2004) Molecular and cellular cognition; the unraveling of memory retrieval. Cell 117, 34.
  • Brun P., Begou M., Andrieux A. et al. (2005) Dopaminergic transmission in STOP null mice. J. Neurochem. 94, 6373.
  • Callicott J., Straub R., Pezawas L. et al. (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl Acad. Sci. USA 102, 86278632.
  • Camargo L. M., Collura V., Rain J. C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T. P., Whiting P. J. and Brandon N. J. (2007) Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12, 7486.
  • Cardno A. G., Marshall E. J., Coid B. et al. (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 56, 162168.
  • Carpenter W. T., Bustillo J. R., Thaker G. K., van Os J., Krueger R. F. and Green M. J. (2009) The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol. Med. 39, 20252042.
  • Chen K., Holschneider D. P., Wu W., Rebrin I. and Shih J. C. (2004) A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J. Biol. Chem. 279, 3964539652.
  • Clapcote S. J., Lipina T. V., Millar J. K. et al. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54, 387402.
  • Craddock N. and Owen M. J. (2005) The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 186, 364366.
  • Craddock N., O’Donovan M. C. and Owen M. J. (2006) Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bull. 32, 916.
  • Delagrange P., Misslin R., Seale T. W., Pfeiffer B., Rault S. and Renard P. (1999) Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxiety. Zhongguo Yao Li Xue Bao 20, 805812.
  • Delotterie D., Ruiz G., Brocard J., Schweitzer A., Roucard C., Roche Y., Suaud-Chagny M. F., Bressand K. and Andrieux A. (2010) Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl), 208 131141.
  • Deltheil T., Guiard B. P., Cerdan J. et al. (2008) Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 55, 10061014.
  • Desbonnet L., Waddington J. L. and Tuathaigh C. M. (2009) Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes? Behav. Brain Res., 204 258273.
  • Detke M. J., Rickels M. and Lucki I. (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121, 6672.
  • Dziedzicka-Wasylewska M., Faron-Gorecka A., Kusmider M., Drozdowska E., Rogoz Z., Siwanowicz J., Caron M. G. and Bonisch H. (2006) Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31, 24242432.
  • Eastwood S. L., Lyon L., George L., Andrieux A., Job D. and Harrison P. J. (2007) Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice. J. Psychopharmacol. 21, 635644.
  • El-Ghundi M., O’Dowd B. F. and George S. R. (2007) Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18, 3766.
  • Fabre V., Beaufour C., Evrard A. et al. (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12, 22992310.
  • Fournet V., Jany M., Fabre V. et al. (2010) The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J. Neurochem. 115, 15791594.
  • Fradley R. L., O’Meara G. F., Newman R. J., Andrieux A., Job D. and Reynolds D. S. (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav. Brain Res. 163, 257264.
  • Franklin K. B. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, Inc., San Diego, CA, USA.
  • Franowicz J. S., Kessler L. E., Borja C. M., Kobilka B. K., Limbird L. E. and Arnsten A. F. (2002) Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci. 22, 87718777.
  • Fukui M., Rodriguiz R. M., Zhou J., Jiang S. X., Phillips L. E., Caron M. G. and Wetsel W. C. (2007) Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 27, 1052010529.
  • Gonzalez-Burgos I. and Feria-Velasco A. (2008) Serotonin/dopamine interaction in memory formation. Prog. Brain Res. 172, 603623.
  • Gras C., Amilhon B., Lepicard E. M. et al. (2008) The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat. Neurosci. 11, 292300.
  • Griebel G., Rodgers R. J., Perrault G. and Sanger D. J. (2000) The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39, 18481857.
  • Gross C., Zhuang X., Stark K., Ramboz S., Ronald O., Kirby L., Santarelli L., Beck S. and Hen R. (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396400.
  • Hanaya R., Koning E., Ferrandon A., Schweitzer A., Andrieux A. and Nehlig A. (2008) Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice. J. Neurosci. Res. 86, 813820.
  • Holmes A., Murphy D. L. and Crawley J. N. (2003) Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54, 953959.
  • Jenkins T. A., Elliott J. J., Ardis T. C., Cahir M., Reynolds G. P., Bell R. and Cooper S. J. (2010) Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone. Behav. Brain Res. 208, 479483.
  • Jennings K. A., Loder M. K., Sheward W. J. et al. (2006) Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 26, 89558964.
  • Ji Y., Yang F., Papaleo F., Wang H. X., Gao W. J., Weinberger D. R. and Lu B. (2009) Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc. Natl. Acad. Sci. USA 106, 1959319598.
  • Kajitani K., Thorne M., Samson M. and Robertson G. S. (2010) Nitric oxide synthase mediates the ability of darbepoetin alfa to improve the cognitive performance of STOP null mice. Neuropsychopharmacology 35, 17181728.
  • Kalueff A. V., Fox M. A., Gallagher P. S. and Murphy D. L. (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav. 6, 389400.
  • Kalueff A. V., Olivier J. D., Nonkes L. J. and Homberg J. R. (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci. Biobehav. Rev. 34, 373386.
  • Kessler R. C., Chiu W. T., Demler O., Merikangas K. R. and Walters E. E. (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617627.
  • Kim D.-K., Tolliver T. J., Huang S.-J., Martin B. J., Andrews A. M., Wichems C. H., Holmes A., Lesch K.-P. and Murphy D. L. (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49, 798810.
  • Kokkinidis L. and Anisman H. (1976) Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task. Pharmacol. Biochem. Behav. 5, 293297.
  • Kusserow H., Davies B., Hortnagl H. et al. (2004) Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res. Mol. Brain Res. 129, 104116.
  • Kvajo M., McKellar H., Arguello P. A., Drew L. J., Moore H., MacDermott A. B., Karayiorgou M. and Gogos J. A. (2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. USA 105, 70767081.
  • Lanfumey L., Mongeau R., Cohen-Salmon C. and Hamon M. (2008) Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci. Biobehav. Rev. 32, 11741184.
  • Lieberman J. A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K. and Gilmore J. (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry 50, 884897.
  • Line S. J., Barkus C., Coyle C., Jennings K. A., Deacon R. M., Lesch K. P., Sharp T. and Bannerman D. M. (2010) Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice. Eur. Neuropsychopharmacol. 21, 108116.
  • Lira A., Zhou M., Castanon N. et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54, 960971.
  • Maier W., Zobel A. and Wagner M. (2006) Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 19, 165170.
  • Masse F., Petit-Demouliere B., Dubois I., Hascoet M. and Bourin M. (2008) Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test. Behav. Brain Res. 188, 291297.
  • Merenlender-Wagner A., Pikman R., Giladi E., Andrieux A. and Gozes I. (2010) NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia. Peptides 31, 13681373.
  • Millan M. J., Dekeyne A., Papp M., La Rochelle C. D., MacSweeny C., Peglion J. L. and Brocco M. (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J. Pharmacol. Exp. Ther. 298, 581591.
  • Mirnics K., Middleton F. A., Lewis D. A. and Levitt P. (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24, 479486.
  • Morice E., Billard J.-M., Denis C., Mathieu F., Betancur C., Epelbaum J., Giros B. and Nosten-Bertrand M. (2007) Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology 32, 21082116.
  • Morris J., Kandpal G., Ma L. and Austin C. (2003) DISC1(disrupted-in-schizophrenia 1) is a centrosome-assciated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss if interaction with mutation. Hum. Mol. Genet. 12, 15911608.
  • Murray R. M., Sham P., Van Os J., Zanelli J., Cannon M. and McDonald C. (2004) A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Res. 71, 405416.
  • Nieoullon A. (2002) Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 5383.
  • Niwa M., Kamiya A., Murai R. et al. (2010) Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 65, 480489.
  • Olivier J. D., Van Der Hart M. G., Van Swelm R. P. et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152, 573584.
  • Ordway G. A., Stockmeier C. A., Cason G. W. and Klimek V. (1997) Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17, 17101719.
  • Perona M. T., Waters S., Hall F. S., Sora I., Lesch K. P., Murphy D. L., Caron M. and Uhl G. R. (2008) Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharmacol. 19, 566574.
  • Pletnikov M., Ayhan Y., Nicholskaia O., Ovanesov M., Huang H., Mori S., Moran T. and Ross C. (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 13, 173186.
  • Popa D., Léna C., Alexandre C. and Adrien J. (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress and behavior. J. Neurosci. 28, 35463554.
  • Porsolt R. D., Bertin A., Blavet N., Deniel M. and Jalfre M. (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57, 201210.
  • Porteous D. J. and Millar J. K. (2006) Disrupted in schizophrenia 1: building brains and memories. Trends Mol. Med. 12, 255261.
  • Powell K. J., Hori S. E., Leslie R., Andrieux A., Schellinck H., Thorne M. and Robertson G. S. (2007) Cognitive impairments in the STOP null mouse model of schizophrenia. Behav. Neurosci. 121, 826835.
  • Radomsky E. D., Haas G. L., Mann J. J. and Sweeney J. A. (1999) Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am. J. Psychiatry 156, 15901595.
  • Richardson-Jones J. W., Craige C. P., Nguyen T. H. et al. (2011) Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. 31, 60086018.
  • Ross C. A., Margolis R. L., Reading S. A., Pletnikov M. and Coyle J. T. (2006) Neurobiology of schizophrenia. Neuron 52, 139153.
  • Savelieva K. V., Zhao S., Pogorelov V. M., Rajan I., Yang Q., Cullinan E. and Lanthorn T. H. (2008) Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 3, e3301.
  • Schaefer T. L., Vorhees C. V. and Williams M. T. (2009) Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 164, 14311443.
  • Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C. and Giros B. (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav. Pharmacol. 11, 279290.
  • Talbot K. (2009) The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research. Prog. Brain Res. 179, 8794.
  • Talbot K., Cho D. S., Ong W. Y. et al. (2006) Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 15, 30413054.
  • Weiss S., Nosten-Bertrand M., McIntosh J. M., Giros B. and Martres M. P. (2007) Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology 32, 24652478.
  • Willner P. (1991) Animal models as simulations of depression. Trends Pharmacol. Sci. 12, 131136.
  • Yalcin I., Belzung C. and Surget A. (2008) Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav. Brain Res. 193, 140143.